Researchers are now on the threshold of human application of stem cell therapies for a class of neurological diseases known as myelin disorders — a long list of diseases that include conditions such as multiple sclerosis, white matter stroke, cerebral palsy, certain dementias, and rare but fatal childhood disorders called pediatric leukodystrophies, experts say.